CClinicalTrials.gg
RecruitingNCT03668821Updated Feb 8, 2023

Frailty in Vascular Patients Undergoing Surgery

An observational study in Vascular Diseases, Carotid Artery Diseases and Aneurysmal Disease, sponsored by Imperial College London. Recruiting at 2 sites in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-02-08.

Sponsored by Imperial College London · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years ago, but the record still lists the study as recruiting.
  • Started Jan 2021; still recruiting 5 years 9 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

An observational cohort study of the frailty of vascular surgery patients undergoing intervention and their outcomes.

Read the detailed description

Vascular surgical operations are major procedures with significant associated morbidity and mortality. Frailty is a major factor influencing surgical outcome, but the effect on morbidity/mortality and quality of life is poorly understood in vascular surgery. Activity levels play a significant role in frailty and in pre-intervention preparation. It is anticipated that as frailty levels increase, activity levels decrease. It is hypothesised that vascular surgery patients suffer from a high prevalence of frailty and that increasing frailty will lead to increased morbidity and mortality and decreased quality of life.

This initial study will provide the foundations to identify targets for improvement in degree of frailty, appropriateness for surgery and outcome.

This project aims to:

Assess and quantify the prevalence of frailty as well as recording activity levels in the vascular surgery patient cohort Explore the impact of frailty and pre-op activity on surgical outcomes in the vascular surgical patient cohort to guide surgical treatments as well as future studies aimed at improving frailty and activity and thereby quality of life.

Identification of an appropriate metric of frailty for this population group to include activity, is a secondary aim of this proposal.

02

Conditions studied

  • Vascular Diseases
  • Carotid Artery Diseases
  • Aneurysmal Disease
  • Peripheral Artery Disease

Keywords

  • Vascular Diseases
  • Peripheral Artery Disease
03

In context

Carotid Artery Diseases

248 studies on the registry are indexed under Carotid Artery Diseases; 56 are open to participants now.

This study's planned enrollment of 300 is above the median of 224 across 108 observational studies indexed under Carotid Artery Diseases.

Browse Carotid Artery Diseases studies →

Lead sponsor

Imperial College London is the lead sponsor of 824 studies on the registry; 178 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 6 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Consecutive patients attending Vascular Surgery department for aortic aneurysm repair, carotid artery surgery and lower limb revascularisation.

Inclusion criteria

  1. All patients attending for aortic aneurysm repair, carotid artery surgery and lower limb revascularisation under the care of the Vascular Surgery team
  2. Willing and able to give informed written consent

Exclusion criteria

Exclusion Criteria:

  1. Those unable to give informed written consent
  2. Those \<18 years of age
  3. In the opinion of the investigator unable or unwilling to comply with the requirements of the study
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Carotid Artery Disease

    Patients with Carotid Artery Disease. Quality of life and frailty questionnaires

    Other: Questionnaire

  • Aneurysmal Disease

    Patients with Aneurysmal Disease. Quality of life and frailty questionnaires

    Other: Questionnaire

  • Peripheral Artery Disease

    Patients with Peripheral Artery Disease. Quality of life and frailty questionnaires

    Other: Questionnaire

Interventions

  • OtherQuestionnaire

    Quality of life and frailty questionnaires

06

What researchers measure

Primary outcomes

  1. Correlation between electronic Frailty Index and survival and complication rate.

    Survival and rate of complication correlated with the pre-operative frailty score (electronic Frailty Index).

    Time frame: 6 months

  2. Correlation between Q Mortality Index and survival and complication rate.

    Survival and rate of complication correlated with the pre-operative frailty score (Q Mortality Index).

    Time frame: 6 months

  3. Correlation between ACS Risk Calculator Score and survival and complication rate.

    Survival and rate of complication correlated with the pre-operative frailty score (ACS Risk Calculator).

    Time frame: 6 months

  4. Correlation between V-Possum and survival and complication rate.

    Survival and rate of complication correlated with the pre-operative frailty score (V-Possum).

    Time frame: 6 months

Secondary outcomes

  1. Activity Levels Pre and Post Surgery as measured by the General Practice Physical Activity Questionnaire

    General Practice Physical Activity Questionnaire will be used to assess patient reported activity before and after surgery.

    Time frame: 6 months

  2. Quality of Life Pre and Post Surgery as measure by the EuroQoL EQ-5D questionnaire

    EuroQol EQ-5D Quality of Life questionnaire will be used to assess patient reported quality of life before and after surgery.

    Time frame: 6 months

07

Study locations

1 of 2 sites recruiting
  • Imperial College London
    London, W6 8RF, United Kingdom
    Not yet recruiting
  • Imperial College Healthcare NHS Trust
    London, W68RF, United Kingdom
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Anonymised data will be allowed to be shared on completion.

Supporting information: Study protocol, Icf, Csr

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03668821
Lead sponsor
Imperial College London
Collaborators
Imperial College Healthcare NHS Trust
Responsible party
Sponsor
First posted
Sep 13, 2018
Start date
Jan 1, 2021
Primary completion
Oct 1, 2024 (estimated)
Completion
Oct 1, 2025 (estimated)
Last update
Feb 8, 2023

Study contacts

Tristan R Lane, PhD FRCS
Contact
tristan.lane@imperial.ac.uk
02033117317
Alun H Davies, DM FRCS
study chair · Imperial College London

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion